Protix Under the Microscope: What the Numbers Say About Its Future After Ynsect
Protix, a Netherlands-based insect protein producer, faces significant financial challenges, reporting flat revenues of €11.8 million in 2024, with substantial operating losses of €22.5 million. Its reliance on external financing raises concerns about its viability, especially following the bankruptcy of Ynsect. The company's future hinges on careful execution of its revised growth strategy and successful capital acquisition.








